Tariq G. Alsahli

Dr. Tariq G. Alsahli

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in Medicina
Verified
Journal Article
Open access
PDF file
SASana Saeed Alqarni
Sana Saeed Alqarni
MAMuhammad Afzal
Muhammad Afzal
KAKhalid Saad Alharbi
Khalid Saad Alharbi
SASattam Khulaif Alenezi
Sattam Khulaif Alenezi
TATariq G. Alsahli
Tariq G. Alsahli
FIFaisal Imam
Faisal Imam
Background and Objectives: Rosiridin is a monoterpene with outstanding monoamine inhibitory activity that is useful to treat depressive episodes and rapid-onset dementia. The current investigation aims to evaluate the neurologically protective impact of rosiridin, which opposes aluminum chloride (AlCl3) and causes memory dysfunction in rats. Materials and Methods: Memory impairment was developed in Wistar rats by administering AlCl3 (100 mg/kg p.o.) orally for 42 days and then supplemented with rosiridin at 10 and 20 mg/kg/p.o. Upon completion of the investigation, the behavior factor was performed utilizing the Y-maze, Morris Water Maze, and open field tests. Estimating numerous biological factors, such as nitric oxide (NO), oxidative stress (malondialdehyde MDA), acetylcholinesterase (AChE), butyrylcholinesterase levels (BuChE), antioxidants (glutathione GSH, catalase CAT, and superoxide dismutases SODs) and neurotransmitter (serotonin-5HT, dopamine-DA, acetylcholine-Ach) in the brain. Furthermore, interleukin-6 (IL-6), IL-1β, tumor necrosis factor (TNF-α), brain-derived neurotrophic factor (BNDF), nuclear factor kappa B (NFᴋB), phosphatidylinositol 3-kinase (PI3K), and pAkt were assessed in the diffused brain cells. Results: The rosiridin-treated group significantly improved in terms of behavioral parameters, including in the Y-maze, Morris Water Maze, and open field tests. Further, rosiridin restored biochemical parameters, including NO, oxidative stress AChE, BuChE, antioxidants, neurotransmitters, IL-6, IL-1β, TNF-α, BNDF, NFᴋB, PI3K, and pAkt compared to AlCl3. Conclusions: The current investigation reveals that rosiridin could ameliorate the impairment of memory that AlCl3 causes in rats via improvements in behavioral and restored biochemical parameters.

28 June 2023 in Gels
Verified
Journal Article
Open access
PDF file
MHMuhammad Ajaz Hussain
Muhammad Ajaz Hussain
AAARSHAD ALI
ARSHAD ALI
TATariq G. Alsahli
Tariq G. Alsahli
NKNadia Khan
Nadia Khan
ASAhsan Sharif
Ahsan Sharif
Syed Nasir Abbas BukhariSyed Nasir Abbas Bukhari
Syed Nasir Abbas Bukhari
The current research work focuses on the extraction and optimization of the hydrogel (AVM) from the seeds of Artemisia vulgaris using Box–Behnken design-response surface methodology (BBD-RSM). The AVM was obtained through a hot water extraction process. The influence of different factors, including pH (U = 4 to 10), temperature (V = 25 to 110 °C), seed/water ratio, i.e., S/W ratio (W = 1/10 to 1/70 w/v), and seed/water contact time, i.e., S/W time (X = 1 to 12 h) on the yield of AVM was evaluated. The p-value for the analysis of variance (ANOVA) was found to be <0.001, indicating that the yield of AVM mainly depended on the abovementioned factors. The highest yield of AVM, i.e., 15.86%, was found at a pH of 7.12, temperature of 80.04 °C, S/W ratio of 1/33.24 w/v, and S/W time of 8.73 h according to Design-Expert Software. The study of the pH-responsive behavior of AVM in tablet form (formulation AVT3) revealed that AVM is a pH-responsive material with significantly high swelling at pH 7.4. However, less swelling was witnessed at pH 1.2. Moreover, AVM was found to be a sustained release material for esomeprazole at pH 7.4 for 12 h. The drug release from AVT3 was according to the super case-II transport mechanism and zero-order kinetics.

30 November 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MTMuhammad Tayyab
Muhammad Tayyab
MHMuhammad Tahir Haseeb
Muhammad Tahir Haseeb
TATariq G. Alsahli
Tariq G. Alsahli
NKNisar Ul Khaliq
Nisar Ul Khaliq
MHMuhammad Ajaz Hussain
Muhammad Ajaz Hussain
Syed Nasir Abbas BukhariSyed Nasir Abbas Bukhari
Syed Nasir Abbas Bukhari

8 March 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
KAKhalid Saad Alharbi
Khalid Saad Alharbi
SASattam Khulaif Alenezi
Sattam Khulaif Alenezi
TATariq G. Alsahli
Tariq G. Alsahli
MAMuhammad Afzal
Muhammad Afzal
MMMohammad J S Mantargi
Mohammad J S Mantargi
NSNadeem Sayyed
Nadeem Sayyed

18 September 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
Syed Nasir Abbas BukhariSyed Nasir Abbas Bukhari
Syed Nasir Abbas Bukhari
TATariq G. Alsahli
Tariq G. Alsahli
Hasan EjazHasan Ejaz
Hasan Ejaz
Naveed AhmadNaveed Ahmad
Naveed Ahmad
WAWaqas Ahmad
Waqas Ahmad
NJNenad Janković
Nenad Janković
The arylidene indolin-2-ones showed significant dual biological activity against MCF-T cancer cell lines and Candida species. The most promising molecule for further investigation contains an m-aminophenyl fragment.

31 August 2025 in Medicina
Verified
Journal Article
Open access
PDF file
SASattam Khulaif Alenezi
Sattam Khulaif Alenezi
KAKhalid Saad Alharbi
Khalid Saad Alharbi
TATariq G. Alsahli
Tariq G. Alsahli
MAMuhammad Afzal
Muhammad Afzal
RAReem ALQahtani
Reem ALQahtani
NSNadeem Sayyed
Nadeem Sayyed
Background and Objectives: Methamphetamine (METH) is a potent psychostimulant known to induce neurotoxicity and neurodegeneration, leading to cognitive impairment. This study aimed to explore cubebin’s potential neuroprotective effects against METH-induced cognitive deficits by investigating its ability to suppress lipid peroxidation and pro-inflammatory markers and modulate neurotransmitter levels. Material and Methods: A total of 30 rats were taken and randomly grouped into five groups: group I—control; group II—METH 100 mg/kg/i.p.; group III—METH + cubebin (10 mg/kg/p.o.); group IV—METH + cubebin (20 mg/kg/p.o.); and group V—cubebin per os at 20 mg/kg. After a 14-day oral regimen, behavioral activities were assessed utilizing the Morris water maze (MWM). Biochemical analysis included neurotransmitters, including dopamine (DA), norepinephrine (NE), and gamma-aminobutyric acid (GABA); oxidative stress markers (malondialdehyde (MDA); nitric oxide (NO), catalase (CAT), reduced glutathione (GSH)); inflammatory cytokines [interleukin (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)]; neurotrophic factors (BDNF, CREB); and apoptotic markers (caspase-3 and caspase-9). Furthermore, molecular docking and simulation studies were conducted. Results: Treatment with cubebin led to a marked reduction in latency during the MWM task. It significantly modulated the oxidative stress markers (SOD, GSH, CAT, MDA, and NO), inflammatory cytokines (IL-6, IL-1β, TNF-α), neurotrophic factors (CREB, BDNF), apoptotic markers (NFkB, caspase-3, caspase-9), and neurotransmitters (NE, DA, and GABA) in METH-induced memory-impaired rats. The results of molecular dynamics simulation (MDS) provided insight into the mechanisms that associate proteins CREB, BDNF, and caspase-3 in conformational dynamics upon binding to cubebin. Conclusions: In conclusion, cubebin administration improved cognitive function in rats by modulating antioxidant enzyme activity, reducing pro-inflammatory cytokines, and regulating neurotransmitter levels, demonstrating its potential neuroprotective effects against MA-induced neurodegeneration.